Literature DB >> 8441739

Comparison of hepatic drug-oxidizing activity after simultaneous administration of two probe drugs, caffeine and trimethadione, to human subjects.

E Tanaka1, A Ishikawa, Y Yamamoto, A Osada, K Tsuji, K Fukao, Y Iwasaki.   

Abstract

Pharmacokinetic interactions between caffeine 2 mg/kg and trimethadione 4 mg/kg were evaluated in 10 healthy volunteers. Whether administered alone or together, the total body clearance (CL), the apparent volume of distribution (Vd) and half-life (t1/2) of caffeine and trimethadione were the same, however, there was a weak correlation between the CL of caffeine and trimethadione [alone: r = 0.51 (P < 0.05); coadministered: r = 0.56 (P < 0.05)]. There were also weak correlations between the CL of trimethadione and the area under the serum concentration-time curves (AUC) of theobromine (r = -0.61, P < 0.05), paraxanthine (r = -0.69, P < 0.05) and theophylline (r = -0.60, P < 0.05), when the two drugs were administered alone. After combined administration, the correlation between the CL of trimethadione and the AUCs of the metabolites of caffeine were as follows: theobromine r = -0.63 (P < 0.05); paraxanthine r = -0.68 (P < 0.05); theophylline r = -0.65 (P < 0.05). These findings suggest that caffeine and trimethadione metabolism in healthy subjects is mediated by only in part by a form(s) of P450 enzymes involved.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8441739     DOI: 10.1111/j.1600-0773.1993.tb01335.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  2 in total

Review 1.  Recent advances in caffeine and theobromine toxicities: a review.

Authors:  M U Eteng; E U Eyong; E O Akpanyung; M A Agiang; C Y Aremu
Journal:  Plant Foods Hum Nutr       Date:  1997       Impact factor: 3.921

Review 2.  Pharmacokinetics of Caffeine: A Systematic Analysis of Reported Data for Application in Metabolic Phenotyping and Liver Function Testing.

Authors:  Jan Grzegorzewski; Florian Bartsch; Adrian Köller; Matthias König
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.